Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Celgene, Agios gain FDA speedy review for AML med enasidenib
The FDA will review Agios and partner Celgene’s NDA for enasidenib (aka AG-221) in relapsed or refractory acute myeloid leukemia (AML) with certain mutations in double quick time, wi...
Chi-Med says cancer drug has passed trials
Hutchison China MediTech (Chi-Med), a pharmaceutical unit controlled by CK Hutchison Holdings (0001), said its drug fruquintinib, which cures colorectal cancer, has shown positive clin...
Study: Reprogrammed blood vessels spur spread of cancer
A team of researchers from the German Cancer Research Center uncovered an activated form of a signaling molecule in blood vessels that can reprogram itself to spread cancer.
Redheads are more likely to develop Parkinson's: Gene that makes gingers susceptible to skin cancer also drives up risk of brain disease, study reveals
Redheads are more likely to get Parkinson's disease, a new study claims.
Big Pharmas, top biotechs balk at investor group's push for pricing transparency
A faith-based investor group’s attempt to learn more about drug pricing is hitting a wall as several corporations are moving to stiff-arm shareholder votes on the issue.
Sanofi launches digital clinical trials
Without clinical trials, new medicine may never make it from the research lab to patients in need.
AIDS Healthcare Foundation Unveils Two New Facilities in Nigeria
ABUJA, Nigeria--The AIDS Healthcare Foundation (AHF) has officially unveiled two newly constructed facilities in Nigeria in partnership with the Benue State Ministry of Health and Benue State ...
Chugai's Anti-IL-31 Receptor A Humanized Monoclonal Antibody "nemolizumab (CIM331)" Global Phase II Study Data Published in The New England Journal of Medicine Online
TOKYO -- Chugai Pharmaceutical Co.
Price drops means more cancer drugs routinely available to patients, says NICE
The National Institute for Health and Care Excellence (NICE) says it is now at the half-way point of its requested review of drugs, approved and still available only through the old Cancer Dru...
Arix Bioscience plc signs strategic agreement with Takeda
LONDON, 2 MARCH 2017.
Mutual Recognition promises new framework for pharmaceutical inspections for United States and European Union
The United States and the European Union (EU) completed an exchange of letters to amend the Pharmaceutical Annex to the 1998 U.
FDA approves house dust mite allergen extract
WASHINGTON — The U.
528
529
530
531
532
533
534
535
536
